- Home
- KGEI vs TERN Comparison
KGEI vs TERN Comparison
Compare KGEI & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- TERN
- Stock Information
- Founded
- KGEI 2008
- TERN 2017
- Country
- KGEI United States
- TERN United States
- Employees
- KGEI N/A
- TERN N/A
- Industry
- KGEI
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- KGEI
- TERN Health Care
- Exchange
- KGEI Nasdaq
- TERN Nasdaq
- Market Cap
- KGEI 262.6M
- TERN 298.1M
- IPO Year
- KGEI N/A
- TERN 2021
- Fundamental
- Price
- KGEI $6.90
- TERN $2.71
- Analyst Decision
- KGEI Strong Buy
- TERN Buy
- Analyst Count
- KGEI 1
- TERN 5
- Target Price
- KGEI $11.00
- TERN $18.38
- AVG Volume (30 Days)
- KGEI 111.5K
- TERN 1.3M
- Earning Date
- KGEI 05-12-2025
- TERN 05-12-2025
- Dividend Yield
- KGEI N/A
- TERN N/A
- EPS Growth
- KGEI N/A
- TERN N/A
- EPS
- KGEI 0.50
- TERN N/A
- Revenue
- KGEI $58,651,000.00
- TERN N/A
- Revenue This Year
- KGEI $39.41
- TERN N/A
- Revenue Next Year
- KGEI $24.46
- TERN N/A
- P/E Ratio
- KGEI $13.70
- TERN N/A
- Revenue Growth
- KGEI 15.91
- TERN N/A
- 52 Week Low
- KGEI $2.85
- TERN $1.87
- 52 Week High
- KGEI $9.89
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- KGEI 43.88
- TERN 49.80
- Support Level
- KGEI $6.75
- TERN $2.22
- Resistance Level
- KGEI $7.47
- TERN $2.43
- Average True Range (ATR)
- KGEI 0.65
- TERN 0.26
- MACD
- KGEI -0.04
- TERN 0.08
- Stochastic Oscillator
- KGEI 22.01
- TERN 83.25
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.